Sangamo BioSciences | SGMO - Ação





Ação Alterar Data
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Bayer EUR 12.33B 221M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Grifols EUR 3.56B 63.19M 2024-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
J&J USD 14.19B 45M 2025-12
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Omeros USD 712K 266K 2021-09
Pfizer USD 11.47B 201M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12